Intellomx works with pharmaceutical, biotechnology, diagnostic and precision-medicine organisations to uncover new biology and translate it into potential therapeutic opportunities.

​

Our commercial relationships can be structured around a specific scientific question, a longer-term research objective or a proprietary discovery programme.

Focused discovery projects

Commission a defined project to investigate a disease pathway, identify and rank targets, assess existing discovery hypotheses, explore biomarkers or link candidate targets to potential molecules.

​

Projects are scoped with agreed questions, data sources, deliverables and validation considerations. A focused initial project may provide the foundation for a broader relationship.

Strategic co-development

Work alongside our scientists to originate, evaluate and advance novel discovery programmes. Collaborations can combine the I³ platform with partner expertise and experimental capabilities, with commercial and intellectual-property arrangements agreed for each programme.

Licensing of proprietary discoveries

Intellomx also undertakes internal discovery programmes using its own technology. Selected target packages, molecular opportunities, biomarker programmes and other internally generated assets may be available for evaluation, option or licensing discussions.

​

Opportunities are at different stages of development; the availability and supporting evidence for each programme can be discussed directly.

How an engagement begins

1. SCIENTIFIC DISCUSSION  —  Tell us the disease area, question or decision that matters.

2. PROJECT DESIGN  —  We review the available data and propose a scope, workplan and outputs.

3. COLLABORATIVE DELIVERY  —  Agree the commercial structure and next steps, including further experiments or development if warranted.

Start with a question worth answering

You do not need to commit to a major strategic relationship to explore the potential of the technology. An introductory discussion can establish whether there is a useful first project. Sensitive information can be considered under an appropriate confidentiality agreement.

​

​

​